APOE and Mental deterioration: Aβ42-α7nAChR complex levels correlate with the rate of cognitive decline in the APOE ε4 carriers (Fig. 6c), and our current data suggest that enhancing the Aβ42-α7nAChR interaction may contribute to apoE4-induced AD pathologies.